JP Morgan Chase’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-30,037
| Closed | -$40.5K | – | 7626 |
|
|
2025
Q3 | $40.5K | Buy |
30,037
+5,353
| +22% | +$6.08K | ﹤0.01% | 6301 |
|
|
2025
Q2 | $23.3K | Sell |
24,684
-63,515
| -72% | -$41.2K | ﹤0.01% | 6140 |
|
|
2025
Q1 | $40.6K | Buy |
88,199
+582
| +0.7% | +$367 | ﹤0.01% | 5950 |
|
|
2024
Q4 | $64.7K | Sell |
87,617
-2,083
| -2% | -$2.51K | ﹤0.01% | 5916 |
|
|
2024
Q3 | $141K | Sell |
89,700
-726
| -0.8% | -$1.29K | ﹤0.01% | 5562 |
|
|
2024
Q2 | $152K | Buy |
90,426
+290
| +0.3% | +$520 | ﹤0.01% | 5297 |
|
|
2024
Q1 | $216K | Sell |
90,136
-2,953,155
| -97% | -$6.34M | ﹤0.01% | 5307 |
|
|
2023
Q4 | $4.66M | Buy |
3,043,291
+228,257
| +8% | +$271K | ﹤0.01% | 3164 |
|
|
2023
Q3 | $3.07M | Sell |
2,815,034
-116,135
| -4% | -$204K | ﹤0.01% | 3207 |
|
|
2023
Q2 | $6.71M | Sell |
2,931,169
-374,822
| -11% | -$995K | ﹤0.01% | 2638 |
|
|
2023
Q1 | $8.03M | Buy |
3,305,991
+29,193
| +0.9% | +$66.9K | ﹤0.01% | 2473 |
|
|
2022
Q4 | $6.26M | Buy |
3,276,798
+50,365
| +2% | +$107K | ﹤0.01% | 2642 |
|
|
2022
Q3 | $7.74M | Buy |
3,226,433
+2,093,656
| +185% | +$5.79M | ﹤0.01% | 2367 |
|
|
2022
Q2 | $2.11M | Buy |
1,132,777
+3,456
| +0.3% | +$6.59K | ﹤0.01% | 3497 |
|
|
2022
Q1 | $2.36M | Sell |
1,129,321
-18,769
| -2% | -$52K | ﹤0.01% | 3624 |
|
|
2021
Q4 | $4.52M | Sell |
1,148,090
-9,613
| -0.8% | -$46.7K | ﹤0.01% | 3144 |
|
|
2021
Q3 | $5.57M | Sell |
1,157,703
-155,458
| -12% | -$638K | ﹤0.01% | 2947 |
|
|
2021
Q2 | $6.03M | Buy |
1,313,161
+919,275
| +233% | +$4.43M | ﹤0.01% | 2893 |
|
|
2021
Q1 | $2.31M | Sell |
393,886
-52,225
| -12% | -$362K | ﹤0.01% | 3611 |
|
|
2020
Q4 | $1.53M | Buy |
446,111
+384,417
| +623% | +$733K | ﹤0.01% | 3681 |
|
|
2020
Q3 | $90K | Buy |
61,694
+41,503
| +206% | +$73.9K | ﹤0.01% | 4744 |
|
|
2020
Q2 | $41K | Buy |
20,191
+105
| +0.5% | +$206 | ﹤0.01% | 4887 |
|
|
2020
Q1 | $39K | Sell |
20,086
-1,067
| -5% | -$3.18K | ﹤0.01% | 4796 |
|
|
2019
Q4 | $87K | Buy |
21,153
+1,782
| +9% | +$6.86K | ﹤0.01% | 4949 |
|
|
2019
Q3 | $58K | Buy |
19,371
+821
| +4% | +$2.54K | ﹤0.01% | 5113 |
|
|
2019
Q2 | $114K | Buy |
18,550
+2,808
| +18% | +$16.8K | ﹤0.01% | 4876 |
|
|
2019
Q1 | $88K | Buy |
15,742
+90
| +0.6% | +$547 | ﹤0.01% | 4931 |
|
|
2018
Q4 | $104K | Buy |
15,652
+1,536
| +11% | +$12.4K | ﹤0.01% | 4835 |
|
|
2018
Q3 | $151K | Sell |
14,116
-42,869
| -75% | -$491K | ﹤0.01% | 4791 |
|
|
2018
Q2 | $684K | Sell |
56,985
-43,324
| -43% | -$443K | ﹤0.01% | 4018 |
|
|
2018
Q1 | $859K | Sell |
100,309
-8,517
| -8% | -$78.8K | ﹤0.01% | 3762 |
|
|
2017
Q4 | $1.07M | Buy |
108,826
+4,785
| +5% | +$49.7K | ﹤0.01% | 3690 |
|
|
2017
Q3 | $1.29M | Sell |
104,041
-4,052
| -4% | -$59.8K | ﹤0.01% | 3390 |
|
|
2017
Q2 | $1.78M | Sell |
108,093
-169,463
| -61% | -$2.62M | ﹤0.01% | 3118 |
|
|
2017
Q1 | $3.98M | Sell |
277,556
-26,654
| -9% | -$395K | ﹤0.01% | 2597 |
|
|
2016
Q4 | $4.21M | Buy |
304,210
+13,360
| +5% | +$214K | ﹤0.01% | 2593 |
|
|
2016
Q3 | $5.26M | Buy |
290,850
+166,157
| +133% | +$2.67M | ﹤0.01% | 2213 |
|
|
2016
Q2 | $1.79M | Sell |
124,693
-6,300
| -5% | -$85.4K | ﹤0.01% | 2872 |
|
|
2016
Q1 | $1.56M | Sell |
130,993
-3,700
| -3% | -$38.8K | ﹤0.01% | 2825 |
|
|
2015
Q4 | $1.79M | Sell |
134,693
-3,000
| -2% | -$36.9K | ﹤0.01% | 2809 |
|
|
2015
Q3 | $1.48M | Buy |
+137,693
| New | +$1.5M | ﹤0.01% | 2904 |
|
|
2013
Q4 | – | Sell |
-13,552
| Closed | -$225K | – | 4179 |
|
|
2013
Q3 | $225K | Sell |
13,552
-87,814
| -87% | -$1.47M | ﹤0.01% | 3999 |
|
|
2013
Q2 | $1.54M | Buy |
+101,366
| New | +$1.54M | ﹤0.01% | 2978 |
|
Other funds holding LXRX
AG
SL
SC
